Merck Pre-Tax Profit Margin 2010-2024 | MKKGY
Current and historical pre-tax profit margin for Merck (MKKGY) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Merck pre-tax profit margin for the three months ending June 30, 2024 was .
| Merck Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-06-30 |
$22.58B |
$3.53B |
15.64% |
| 2024-03-31 |
$22.60B |
$3.66B |
16.20% |
| 2023-12-31 |
$22.72B |
$3.77B |
16.60% |
| 2023-09-30 |
$22.91B |
$3.93B |
17.15% |
| 2023-06-30 |
$23.13B |
$4.11B |
17.75% |
| 2023-03-31 |
$23.27B |
$4.33B |
18.58% |
| 2022-12-31 |
$23.42B |
$4.52B |
19.28% |
| 2022-09-30 |
$23.58B |
$4.80B |
20.37% |
| 2022-06-30 |
$23.60B |
$4.78B |
20.25% |
| 2022-03-31 |
$23.54B |
$4.74B |
20.11% |
| 2021-12-31 |
$23.29B |
$4.64B |
19.93% |
| 2021-09-30 |
$22.79B |
$4.16B |
18.25% |
| 2021-06-30 |
$22.12B |
$4.23B |
19.13% |
| 2021-03-31 |
$20.79B |
$3.51B |
16.88% |
| 2020-12-31 |
$20.03B |
$3.00B |
15.00% |
| 2020-09-30 |
$19.42B |
$2.84B |
14.64% |
| 2020-06-30 |
$18.73B |
$2.12B |
11.34% |
| 2020-03-31 |
$18.66B |
$2.32B |
12.45% |
| 2019-12-31 |
$18.09B |
$1.94B |
10.75% |
| 2019-09-30 |
$17.42B |
$1.72B |
9.89% |
| 2019-06-30 |
$17.27B |
$1.70B |
9.86% |
| 2019-03-31 |
$17.24B |
$1.47B |
8.51% |
| 2018-12-31 |
$17.52B |
$1.73B |
9.85% |
| 2018-09-30 |
$17.87B |
$1.65B |
9.22% |
| 2018-06-30 |
$17.90B |
$2.13B |
11.87% |
| 2018-03-31 |
$17.75B |
$2.35B |
13.23% |
| 2017-12-31 |
$17.32B |
$2.52B |
14.52% |
| 2017-09-30 |
$16.90B |
$2.68B |
15.88% |
| 2017-06-30 |
$16.68B |
$2.38B |
14.28% |
| 2017-03-31 |
$16.70B |
$2.25B |
13.49% |
| 2016-12-31 |
$16.63B |
$2.38B |
14.34% |
| 2016-09-30 |
$16.29B |
$2.20B |
13.50% |
| 2016-06-30 |
$15.63B |
$2.06B |
13.16% |
| 2016-03-31 |
$14.89B |
$2.08B |
13.98% |
| 2015-12-31 |
$14.31B |
$1.65B |
11.53% |
| 2015-09-30 |
$13.91B |
$1.92B |
13.80% |
| 2015-06-30 |
$14.32B |
$1.88B |
13.10% |
| 2015-03-31 |
$14.59B |
$1.90B |
13.05% |
| 2014-12-31 |
$14.78B |
$2.07B |
14.00% |
| 2014-09-30 |
$15.11B |
$1.90B |
12.60% |
| 2014-06-30 |
$14.86B |
$1.98B |
13.33% |
| 2014-03-31 |
$14.80B |
$1.99B |
13.44% |
| 2013-12-31 |
$14.72B |
$1.84B |
12.52% |
| 2013-09-30 |
$14.64B |
$5.21B |
35.59% |
| 2013-06-30 |
$14.55B |
$4.97B |
34.12% |
| 2013-03-31 |
$14.30B |
$4.36B |
30.49% |
| 2012-12-31 |
$14.00B |
$7.19B |
51.34% |
| 2012-09-30 |
$13.66B |
$6.85B |
50.15% |
| 2012-06-30 |
$13.69B |
$10.11B |
73.85% |
| 2012-03-31 |
$13.85B |
$10.03B |
72.43% |
| 2011-12-31 |
$14.08B |
$10.26B |
72.89% |
| 2011-09-30 |
$14.47B |
$13.43B |
92.78% |
| 2011-06-30 |
$14.03B |
$10.22B |
72.80% |
| 2011-03-31 |
$13.05B |
$13.05B |
100.00% |
| 2010-12-31 |
$12.34B |
$12.34B |
100.00% |
| 2010-09-30 |
$11.61B |
$8.84B |
76.13% |
| 2010-06-30 |
$11.25B |
$11.25B |
100.00% |
| 2010-03-31 |
$11.14B |
$11.14B |
100.00% |
| 2009-12-31 |
$10.81B |
$10.81B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
